OCC 2.50% 39.0¢ orthocell limited

Ann: Investor Update, page-21

  1. 1,899 Posts.
    lightbulb Created with Sketch. 96
    Anyone can explain why Polynovo is used as medicine case study in today's investor update? P17. redface.png
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.